Prescription Required
Caution is advised when consuming alcohol with Lamistar 150 mg/30 mg Tablet. Please consult your doctor.
Lamistar 150 mg/30 mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Lamistar 150 mg/30 mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Lamistar 150 mg/30 mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Lamistar 150 mg/30 mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Lamistar 150 mg/30 mg Tablet may be needed. Please consult your doctor.
Lamistar 150 mg/30 mg Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Lamistar 150 mg/30 mg Tablet may not be needed in these patients. Please consult your doctor.<BR>Inform your doctor if you develop any signs and symptoms of jaundice while taking Lamistar 150 mg/30 mg Tablet. You may need to stop taking this medicine.
Lamistar 150 mg/30 mg Tablet is a combination of two anti-HIV medicines: Lamivudine and Stavudine. They prevent HIV (virus) from multiplying, thereby reducing the amount of virus in your body. They also increase the CD4 cell (white blood cells that protect against infection) count in your blood.
Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA